At Scibase we are on a mission to improving patient's lives through developing accurate detection of skin conditions. We are experiencing rapid growth in our core European market, particularly Germany. Our EU product usage increased in 2022 where we welcomed over 50% new customers. We proudly hold MDR certification in Europe which decreases the barrier to entry for competitors. Our product Nevisense is the only point of care device available for melanoma detection in the US and our presence in the US market holds immense growth potential.